Nilotinib Affects Biomarkers in Alzheimer's Disease: Trial

Nilotinib appears safe, well tolerated and affects biomarkers in Alzheimer's disease, according to the results of a clinical trial.

from Medindia Health News https://ift.tt/2XFrUW2